Burkhard Ludewig mainly focuses on Immunology, Cell biology, Virology, Cytotoxic T cell and Immune system. His T cell, Antigen, Lymphocytic choriomeningitis, CD8 and Adoptive cell transfer study are his primary interests in Immunology. His Cell biology research integrates issues from Stromal cell, Lymphatic system, Pathology, Cytokine and Reticular cell.
When carried out as part of a general Virology research project, his work on Viral replication, Virus and Interferon is frequently linked to work in Coronavirus, therefore connecting diverse disciplines of study. His Interferon research is multidisciplinary, incorporating elements of Non-coding RNA, 2'-O-methylation, Gene expression, eIF4A and RNA-binding protein. His work on CTL* as part of general Immune system research is frequently linked to Apolipoprotein B, bridging the gap between disciplines.
Burkhard Ludewig mainly investigates Immunology, Cell biology, Immune system, Virology and T cell. Burkhard Ludewig works mostly in the field of Immunology, limiting it down to topics relating to Cytotoxic T cell and, in certain cases, Dendritic cell and Immunotherapy. His Cell biology study incorporates themes from Cell, Stromal cell, Reticular cell, Lymph node and Lymphatic system.
Burkhard Ludewig has researched Immune system in several fields, including Inflammation, Cancer and Disease. His Virus and Viral replication study, which is part of a larger body of work in Virology, is frequently linked to Coronavirus and Mouse hepatitis virus, bridging the gap between disciplines. His biological study spans a wide range of topics, including Epitope, CD40 and Monocyte.
His primary scientific interests are in Cell biology, Immune system, Stromal cell, Reticular cell and Immunology. His Cell biology research includes themes of Cell, Transcriptome, CD8, Lymph node and Lymphatic system. His Immune system research incorporates elements of Cancer, Disease, Homeostasis and Virology.
His Stromal cell research focuses on Lymph and how it relates to Genetic model. His research integrates issues of T cell, Germinal center, B cell, Chemokine and Follicular dendritic cells in his study of Reticular cell. His Immunology study frequently draws connections to adjacent fields such as Myocarditis.
His primary areas of study are Cell biology, Reticular cell, T cell, Immune system and Lymphatic system. His Cell biology research includes elements of Interferon, Stromal cell and Lymph node. His work in Stromal cell tackles topics such as Antibody which are related to areas like Antigen.
To a larger extent, Burkhard Ludewig studies Immunology with the aim of understanding T cell. Immunology is closely attributed to Efferocytosis in his study. His Immune system research is multidisciplinary, relying on both Cell, Macrophage, Virus and Effector.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use of flow cytometry and cell sorting in immunological studies
Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis.
European Journal of Immunology (2017)
Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5
Roland Züst;Roland Züst;Luisa Cervantes-Barragan;Matthias Habjan;Reinhard Maier.
Nature Immunology (2011)
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs.
European Journal of Immunology (2019)
Immune surveillance against a solid tumor fails because of immunological ignorance.
Adrian F. Ochsenbein;Paul Klenerman;Urs Karrer;Burkhard Ludewig.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon.
Luisa Cervantes-Barragan;Roland Züst;Friedemann Weber;Martin Spiegel.
Blood (2007)
Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone.
Elke Scandella;Beatrice Bolinger;Evelyn Lattmann;Simone Miller.
Nature Immunology (2008)
Dendritic Cells Induce Autoimmune Diabetes and Maintain Disease via De Novo Formation of Local Lymphoid Tissue
Burkhard Ludewig;Bernhard Odermatt;Salome Landmann;Hans Hengartner.
Journal of Experimental Medicine (1998)
Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease.
Burkhard Ludewig;Adrian F. Ochsenbein;Bernhard Odermatt;Denise Paulin.
Journal of Experimental Medicine (2000)
Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence
Tobias Junt;Elke Scandella;Burkhard Ludewig.
Nature Reviews Immunology (2008)
Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10
Burkhard Ludewig;Daniel Graf;Hans R. Gelderblom;Yechiel Becker.
European Journal of Immunology (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Bern
University of Zurich
University of Zurich
University of Zurich
Novartis (Switzerland)
Pompeu Fabra University
University of Oxford
University of Lausanne
Johannes Gutenberg University of Mainz
University of Veterinary Medicine Vienna
EURECOM
Harvard University
Singapore Management University
Chinese Academy of Sciences
University of Saskatchewan
Trent University
University of Utah
University College Dublin
United States Military Academy
National Taiwan Normal University
Birkbeck, University of London
Montana State University
National Institute of Allergy and Infectious Diseases
University of Glasgow
University of Padua
University of California, Berkeley